These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28267544)

  • 1. First ultrasound diagnosis of BI-RADS 3 lesions in young patients: Can 6-months follow-up be sufficient to assess stability?
    Marcon M; Frauenfelder T; Becker AS; Dedes KJ; Boss A
    Eur J Radiol; 2017 Apr; 89():226-233. PubMed ID: 28267544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonpalpable BI-RADS 4 breast lesions: sonographic findings and pathology correlation.
    Elverici E; Barça AN; Aktaş H; Özsoy A; Zengin B; Çavuşoğlu M; Araz L
    Diagn Interv Radiol; 2015; 21(3):189-94. PubMed ID: 25835079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ultrasound follow-up of palpable solid, probably benign breast lesions (BI-RADS category III)].
    Graf O; Helbich TH; Fuchsjäger MH; Hopf G; Morgun M; Graf C; Mallek R
    Rofo; 2004 Sep; 176(9):1251-6. PubMed ID: 15346259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and outcomes of biopsy-proven fibroadenomas recommended for surgical excision.
    Lee S; Mercado CL; Cangiarella JF; Chhor CM
    Clin Imaging; 2018; 50():31-36. PubMed ID: 29258029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Imaging-Reporting and Data System (BI-RADS) classification in 51 excised palpable pediatric breast masses.
    Koning JL; Davenport KP; Poole PS; Kruk PG; Grabowski JE
    J Pediatr Surg; 2015 Oct; 50(10):1746-50. PubMed ID: 25783351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated breast ultrasound: lesion detection and BI-RADS classification--a pilot study.
    Wenkel E; Heckmann M; Heinrich M; Schwab SA; Uder M; Schulz-Wendtland R; Bautz WA; Janka R
    Rofo; 2008 Sep; 180(9):804-8. PubMed ID: 18704878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient compliance and diagnostic yield of 18-month unilateral follow-up in surveillance of probably benign mammographic lesions.
    Chung CS; Giess CS; Gombos EC; Frost EP; Yeh ED; Raza S; Birdwell RL
    AJR Am J Roentgenol; 2014 Apr; 202(4):922-7. PubMed ID: 24660725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reassessment and Follow-Up Results of BI-RADS Category 3 Lesions Detected on Screening Breast Ultrasound.
    Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
    AJR Am J Roentgenol; 2016 Mar; 206(3):666-72. PubMed ID: 26901026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of probably benign (BI-RADS 3) lesions in mammography: what is the right follow-up protocol?
    Buch KA; Qureshi MM; Carpentier B; Cunningham DA; Stone M; Jaffe C; Quinn M; Gonzalez C; LaVoye J; Hines N; Bloch BN
    Breast J; 2015; 21(2):168-74. PubMed ID: 25669425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The differences of phyllodes and acoustic attenuation in breast lesions diagnosed with Breast Imaging-Reporting and Data System for Ultrasonography (BI-RADS-US) category 4C.
    Li YY; Liu C; Geng J; Li JG; Jin F; Wang XM
    Eur J Gynaecol Oncol; 2015; 36(3):294-7. PubMed ID: 26189256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of age on PPV of sonographic BI-RADS categories 3, 4, and 5.
    Fu CY; Hsu HH; Yu JC; Hsu GC; Hsu KF; Chan DC; Ku CH; Lu TC; Chu CH
    Ultraschall Med; 2011 Jan; 32 Suppl 1():S8-13. PubMed ID: 20603785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasonography and core needle biopsy in the differential diagnosis of fibroadenoma and tumor phyllodes.
    Bode MK; Rissanen T; Apaja-Sarkkinen M
    Acta Radiol; 2007 Sep; 48(7):708-13. PubMed ID: 17728999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is a one-year follow-up an efficient method for better management of MRI BI-RADS(®) 3 lesions?
    Boisserie-Lacroix M; Ziadé C; Hurtevent-Labrot G; Ferron S; Brouste V; Lippa N
    Breast; 2016 Jun; 27():1-7. PubMed ID: 27212693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign Phyllodes Tumor of the Breast Diagnosed After Ultrasound-Guided Vacuum-Assisted Biopsy: Surgical Excision or Wait-and-Watch?
    Ouyang Q; Li S; Tan C; Zeng Y; Zhu L; Song E; Chen K; Su F
    Ann Surg Oncol; 2016 Apr; 23(4):1129-34. PubMed ID: 26577125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Texture Analysis of Ultrasound Images to Differentiate Simple Fibroadenomas From Complex Fibroadenomas and Benign Phyllodes Tumors.
    Basara Akin I; Ozgul H; Simsek K; Altay C; Secil M; Balci P
    J Ultrasound Med; 2020 Oct; 39(10):1993-2003. PubMed ID: 32329531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of Short-Term Follow-Up in BI-RADS 3 and 4a Breast Lesions with a Histological Diagnosis of Fibroadenoma at Percutaneous Needle Biopsy.
    Clauser P; Bazzocchi M; Marcon M; Londero V; Zuiani C
    Breast Care (Basel); 2017 Sep; 12(4):238-242. PubMed ID: 29070987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation between phyllodes tumor and fibroadenoma using real-time elastography.
    Adamietz BR; Kahmann L; Fasching PA; Schulz-Wendtland R; Uder M; Beckmann MW; Meier-Meitinger M
    Ultraschall Med; 2011 Dec; 32 Suppl 2():E75-9. PubMed ID: 22194044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BI-RADS 3, 4, and 5 lesions: value of US in management--follow-up and outcome.
    Raza S; Chikarmane SA; Neilsen SS; Zorn LM; Birdwell RL
    Radiology; 2008 Sep; 248(3):773-81. PubMed ID: 18647850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroepithelial Lesions (FELs) of the Breast: Is Routine Excision Always Necessary?
    Limberg J; Barker K; Hoda S; Simmons R; Michaels A; Marti JL
    World J Surg; 2020 May; 44(5):1552-1558. PubMed ID: 31974650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shear-wave elastography and greyscale assessment of palpable probably benign masses: is biopsy always required?
    Giannotti E; Vinnicombe S; Thomson K; McLean D; Purdie C; Jordan L; Evans A
    Br J Radiol; 2016 Jun; 89(1062):20150865. PubMed ID: 27007593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.